CALM3

Across TCGA pan-cancer cohorts, CALM3 Mutation is linked to patient survival in 2 of 34 cancer types, making it a survival-associated CALM3 data layer compared with 26 for mass-spec protein.

The strongest signal is observed in thymoma (THYM), where higher CALM3 Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated CALM3 expression acts as an unfavorable survival marker.

THYM and LUAD are the cancer types where CALM3 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
THYM	OS	Median	III,IV	0.103	0.944	<.001	42	view →
LUAD	OS	Median	All	0.313	0.812	.015	9	view →

Pink = unfavorable, green = favorable. Showing the 2 strongest of 2 lineages.

CALM3–THYM (OS)

Open the THYM breakdown →